SpaceX Stock Is Down 17% Since Its IPO. Here's What a $10,000 Investment Could Look Like in 5 Years. NASDAQ · markets 26m ago Read
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests NASDAQ · markets 29m ago Read
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know NASDAQ · markets 41m ago Read
Nvidia lines up $500 billion in financing as CEO Jensen Huang tells CNBC his chips are ‘investable asset’ CNBC · markets 42m ago Read
Stock futures are steady as investors weigh Iran, Hormuz deal prospects: Live updates CNBC · markets 47m ago Read
Stock futures are steady as investors weigh Iran, Hormuz deal prospects: Live updates CNBC · economy 47m ago Read
A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It NASDAQ · markets 49m ago Read
A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know NASDAQ · markets 56m ago Read
Airbnb Is Starting To Think Like Amazon's Jeff Bezos, And It's Paying Off NASDAQ · markets 1h ago Read
Why Kevin Warsh Might Raise Interest Rates at the Next FOMC Meeting, Despite a Weak Jobs Report NASDAQ · markets 1h ago Read
Stock Market Today, Aug. 10: Markets Slip as Oil Gains Fuel Inflation Fears NASDAQ · markets 1h ago Read
Archer Aviation Just Bought a $200 Million Defense Business From Boeing -- by Giving Up 20% of the Company NASDAQ · markets 1h ago Read
A Toast Insider Cashed In Options as the Stock Recouped Losses. Here's What to Know NASDAQ · markets 1h ago Read
Semiconductor Equipment Makers vs. Chip Designers: Who's Actually Winning the AI Cycle? NASDAQ · markets 2h ago Read
Canadian Stocks Inch Higher Amid Increasing Middle East Tensions, Ongoing Canada-US Talks NASDAQ · markets 2h ago Read
'Genius' Ingebrigtsen surges late to win European 5,000m gold after injury BBC Sport · sports 2h ago Read
Here's how the market may react to July's CPI report, according to JPMorgan CNBC · economy 2h ago Read
Braveheart Bio CFO Acquires 27,777 Shares for $500,000. Is This a Signal BRVE IPO Is a Success? NASDAQ · markets 2h ago Read
Iovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher? NASDAQ · markets 3h ago Read
Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors? NASDAQ · markets 3h ago Read
Berkshire's Biggest Repurchase in Nearly Two Years Shrank the Share Count by 0.4% NASDAQ · markets 3h ago Read
